These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 20462645

  • 1. Improvement of endothelial dysfunction in atherosclerotic rabbit aortas by ex vivo gene transferring of dimethylarginine dimethylaminohydrolase-2.
    Feng M, He ZM, Zhu YX, Liu LH, Lu CW, Xiong Y.
    Int J Cardiol; 2010 Oct 08; 144(2):180-6. PubMed ID: 20462645
    [Abstract] [Full Text] [Related]

  • 2. Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells.
    Lu CW, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Atherosclerosis; 2010 Mar 08; 209(1):66-73. PubMed ID: 19775692
    [Abstract] [Full Text] [Related]

  • 3. Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits.
    Lin Y, Feng M, Lu CW, Lei YP, He ZM, Xiong Y.
    Eur J Pharmacol; 2017 Mar 05; 798():43-48. PubMed ID: 28163022
    [Abstract] [Full Text] [Related]

  • 4. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S, Ueda S, Okuda S.
    Med Hypotheses; 2007 Mar 05; 69(4):922-4. PubMed ID: 17368960
    [Abstract] [Full Text] [Related]

  • 5. Phosphorylation of Nonmuscle Myosin Light Chain Promotes Endothelial Injury in Hyperlipidemic Rats Through a Mechanism Involving Downregulation of Dimethylarginine Dimethylaminohydrolase 2.
    Wu Y, Zhang JJ, Li TB, Liu WQ, Li LS, Luo XJ, Jiang JL, Ma QL, Yang ZC, Peng J.
    J Cardiovasc Pharmacol Ther; 2016 Nov 05; 21(6):536-548. PubMed ID: 26911182
    [Abstract] [Full Text] [Related]

  • 6. Dimethylarginine dimethylaminohydrolase 2 increases vascular endothelial growth factor expression through Sp1 transcription factor in endothelial cells.
    Hasegawa K, Wakino S, Tanaka T, Kimoto M, Tatematsu S, Kanda T, Yoshioka K, Homma K, Sugano N, Kurabayashi M, Saruta T, Hayashi K.
    Arterioscler Thromb Vasc Biol; 2006 Jul 05; 26(7):1488-94. PubMed ID: 16574895
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of atherosclerosis through transplantation of endothelial progenitor cells overexpressing dimethylarginine dimethylaminohydrolase (DDAH) in rabbits.
    Shoeibi S, Mahdipour E, Mohammadi S, Moohebati M, Ghayour-Mobarhan M.
    Int J Cardiol; 2021 May 15; 331():189-198. PubMed ID: 33535073
    [Abstract] [Full Text] [Related]

  • 9. Dimethylarginine dimethylaminohydrolase (DDAH)--a critical regulator of hypertensive left ventricular hypertrophy?
    Bai Y, Hui R.
    Med Hypotheses; 2008 May 15; 70(5):962-6. PubMed ID: 17983707
    [Abstract] [Full Text] [Related]

  • 10. Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule.
    Fliser D.
    Eur J Clin Invest; 2005 Feb 15; 35(2):71-9. PubMed ID: 15667575
    [Abstract] [Full Text] [Related]

  • 11. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
    Monsalve E, Oviedo PJ, García-Pérez MA, Tarín JJ, Cano A, Hermenegildo C.
    Cardiovasc Res; 2007 Jan 01; 73(1):66-72. PubMed ID: 17097077
    [Abstract] [Full Text] [Related]

  • 12. Gene therapy for dysfunctional endothelium: is dimethylarginine dimethylaminohydrolase-2 a therapeutic target?
    Tousoulis D, Antoniades C, Tsiamis E, Charakida M, Siasos G, Tsioufis C, Stefanadis C.
    Int J Cardiol; 2010 Oct 08; 144(2):173-4. PubMed ID: 20538358
    [No Abstract] [Full Text] [Related]

  • 13. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension.
    Okubo K, Hayashi K, Wakino S, Matsuda H, Kubota E, Honda M, Tokuyama H, Yamamoto T, Kajiya F, Saruta T.
    Hypertens Res; 2005 Feb 08; 28(2):181-9. PubMed ID: 16025746
    [Abstract] [Full Text] [Related]

  • 14. All-trans retinoic acid inhibits cobalt chloride-induced apoptosis in PC12 cells: role of the dimethylarginine dimethylaminohydrolase/asymmetric dimethylarginine pathway.
    Wang S, Hu CP, Jiang DJ, Peng J, Zhou Z, Yuan Q, Nie SD, Jiang JL, Li YJ, Huang KL.
    J Neurosci Res; 2009 Jun 08; 87(8):1938-46. PubMed ID: 19156866
    [Abstract] [Full Text] [Related]

  • 15. Dimethylarginine dimethylaminohydrolase (DDAH) regulates trophoblast invasion and motility through effects on nitric oxide.
    Ayling LJ, Whitley GS, Aplin JD, Cartwright JE.
    Hum Reprod; 2006 Oct 08; 21(10):2530-7. PubMed ID: 16920729
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
    Selley ML.
    J Neurosci Res; 2004 Jul 01; 77(1):90-3. PubMed ID: 15197741
    [Abstract] [Full Text] [Related]

  • 18. Regulation of endothelial progenitor cell differentiation and function by dimethylarginine dimethylaminohydrolase 2 in an asymmetric dimethylarginine-independent manner.
    Yuan Q, Bai YP, Shi RZ, Liu SY, Chen XM, Chen L, Li YJ, Hu CP.
    Cell Biol Int; 2014 Sep 01; 38(9):1013-22. PubMed ID: 24764313
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients.
    Mannino GC, Pezzilli S, Averta C, Fuoco A, Spiga R, Mancuso E, Di Fatta C, Perticone F, Prudente S, Trischitta V, Andreozzi F, Sesti G.
    Cardiovasc Diabetol; 2019 Aug 13; 18(1):102. PubMed ID: 31409409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.